Two independent studies observed that elevated tissue TGF-β levels were correlated with shorter disease-free survival and lymph node metastasis [34, 35], while conversely, two other studies reported an association between higher tissue TGF-β levels and favorable tumor features, including reduced metastasis [36, 37]. Here, TGFB1 is linked to metastatic malignant neoplasm in the lymph nodes.